Security key
03828A101
KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (APLT)
CUSIP: 03828A101
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 112,721,874
- Total 13F value
- $960,819,113
- Share change
- +7,359,683
- Put/Call ratio
- 134%
- SEC-reported price per share
- $8.50
- Number of holders
- 125
- Value change
- +$78,176,113
- Number of buys
- 76
- Number of sells
- 46
- Shares outstanding
- 143,223,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
125
Top holders
10
APLT full security history
Ownership snapshot
Full 13F holder table
KalVista Pharmaceuticals, Inc. SEC filings
KalVista Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of APLT - KalVista Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FRANKLIN TEMPLETON INC
Disclosed value leader
FRANKLIN TEMPLETON INC
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F
Highest disclosed value: $47,694,453
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRANKLIN TEMPLETON INC has the largest disclosed position value at $47.69M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRANKLIN TEMPLETON INC's linked filing trail.
Disclosed position value
Top 5
FRANKLIN TEMPLETON INC
$47.69M
Venrock Adviser, LLC
$44.57M
PERCEPTIVE ADVISORS LLC
$37.38M
Janus Henderson Group Ltd.
$35.49M
BlackRock Finance, Inc.
$30.68M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$47,694,453
10,212,945 shares
|
— | 30 Jun 2024 |
| Venrock Adviser, LLC |
13F
Company
|
—
denominator unverified
|
$44,565,208
9,542,871 shares
|
— | 30 Jun 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$37,383,350
8,005,000 shares
|
— | 30 Jun 2024 |
| Janus Henderson Group Ltd. |
13F
Company
|
—
denominator unverified
|
$35,487,671
7,648,205 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$30,680,905
6,569,787 shares
|
— | 30 Jun 2024 |
| Propel Bio Management, LLC |
13F
Company
|
—
denominator unverified
|
$30,671,897
6,567,858 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
125
Shares
112,721,874
Rows available
125
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
92
Q3 2024 holders
125
Holder diff
33
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|